Research awards:

• ASCO Conquer Cancer Merit Award, 2022, 2023
• EHA Travel Grant Award, 2022
• ASH Abstract Achievement Award 2023
• Research Fellow of the year (2021-2022), Department o... Show more

Research awards:

• ASCO Conquer Cancer Merit Award, 2022, 2023
• EHA Travel Grant Award, 2022
• ASH Abstract Achievement Award 2023
• Research Fellow of the year (2021-2022), Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston,
• Clinical Fellow of the year (2022-2023), Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston,
• Hematocon (ISHBT) 2016 first prize for best oral paper in malignant clinical hematology

Publications:

• Short NJ, Senapati J, Jabbour E. An Update on the Management of Advanced Phase Chronic Myeloid Leukemia. Curr Hematol Malig Rep. 2023.
• Senapati J, Panda T, Rajendra A, Aggarwal M. Understanding the barriers to AML care in India. The Lancet Haematology. 2023;10(9):e710-e1.
• Senapati J, Fiskus WC, Daver N, et al. Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clin Cancer Res 2023 (In eng). DOI: 10.1158/1078-0432.Ccr-23-1429.
• Senapati J, Urrutia S, Loghavi S, et al. Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia. Blood 2023 (In eng). DOI: 10.1182/blood.2023020649